$13.6 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 97 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 39.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRcall | $1,873,150,000 | – | 7,495,000 | +100.0% | 13.73% | – |
| AABA | Buy | ALTABA INC | $1,599,568,000 | +10.6% | 27,607,317 | +30.0% | 11.73% | +37.2% |
| FOXA | Buy | TWENTY FIRST CENTY FOX INCcl a | $615,565,000 | +825.9% | 12,792,300 | +791.4% | 4.51% | +1048.3% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $480,942,000 | +28.0% | 464,405 | +47.6% | 3.53% | +58.9% |
| RHT | New | RED HAT INC | $471,593,000 | – | 2,685,000 | +100.0% | 3.46% | – |
| FB | Buy | FACEBOOK INCcl a | $399,975,000 | -2.2% | 3,051,148 | +22.7% | 2.93% | +21.4% |
| EQIX | Buy | EQUINIX INC | $391,656,000 | +48.7% | 1,110,892 | +82.5% | 2.87% | +84.6% |
| WAB | Buy | WABTEC CORP | $388,557,000 | +5.8% | 5,531,059 | +58.0% | 2.85% | +31.4% |
| IQV | Buy | IQVIA HLDGS INC | $373,987,000 | -5.2% | 3,219,308 | +5.9% | 2.74% | +17.7% |
| FOX | Buy | TWENTY FIRST CENTY FOX INCcl b | $370,056,000 | +50.7% | 7,745,000 | +44.5% | 2.71% | +87.0% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $307,905,000 | -20.1% | 1,080,481 | -8.7% | 2.26% | -0.9% |
| V | Buy | VISA INC | $306,065,000 | +3.3% | 2,319,726 | +17.6% | 2.24% | +28.3% |
| TRU | Buy | TRANSUNION | $299,264,000 | +18.7% | 5,268,739 | +53.7% | 2.19% | +47.2% |
| BKNG | Buy | BOOKING HLDGS INC | $285,030,000 | +12.0% | 165,482 | +29.0% | 2.09% | +39.1% |
| INFO | Buy | IHS MARKIT LTD | $283,983,000 | +4.1% | 5,920,016 | +17.1% | 2.08% | +29.2% |
| ANTM | Buy | ANTHEM INC | $275,762,000 | -2.8% | 1,050,000 | +1.4% | 2.02% | +20.7% |
| MSFT | Buy | MICROSOFT CORP | $262,952,000 | +6.5% | 2,588,874 | +19.9% | 1.93% | +32.1% |
| GD | Sell | GENERAL DYNAMICS CORP | $255,967,000 | -29.4% | 1,628,186 | -8.0% | 1.88% | -12.3% |
| PLYA | PLAYA HOTELS & RESORTS NV | $220,064,000 | -25.3% | 30,606,930 | 0.0% | 1.61% | -7.4% | |
| CI | New | CIGNA CORP NEW | $200,366,000 | – | 1,055,000 | +100.0% | 1.47% | – |
| EFX | Buy | EQUIFAX INC | $199,819,000 | +87.6% | 2,145,594 | +163.0% | 1.46% | +132.9% |
| FIS | Sell | FIDELITY NATL INFORMATION SV | $194,779,000 | -9.0% | 1,899,355 | -3.2% | 1.43% | +13.0% |
| SMH | New | VANECK VECTORS ETF TRput | $187,652,000 | – | 2,150,000 | +100.0% | 1.38% | – |
| DELL | New | DELL TECHNOLOGIES INCcl c | $174,567,000 | – | 3,572,062 | +100.0% | 1.28% | – |
| SPY | Sell | SPDR S&P 500 ETF TRput | $173,195,000 | -93.6% | 693,000 | -92.5% | 1.27% | -92.0% |
| TLRY | TILRAY INC | $162,074,000 | -43.2% | 2,479,515 | 0.0% | 1.19% | -29.5% | |
| VRSK | Buy | VERISK ANALYTICS INC | $157,148,000 | -8.5% | 1,441,194 | +1.2% | 1.15% | +13.6% |
| CTXS | Sell | CITRIX SYS INC | $150,435,000 | -25.3% | 1,468,234 | -19.0% | 1.10% | -7.3% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $147,552,000 | +9.0% | 3,885,000 | +13.6% | 1.08% | +35.4% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $143,924,000 | +134.2% | 1,050,000 | +181.5% | 1.06% | +190.6% |
| LBTYA | Sell | LIBERTY GLOBAL PLC | $127,452,000 | -33.5% | 5,972,437 | -9.9% | 0.93% | -17.6% |
| TSRO | New | TESARO INC | $126,225,000 | – | 1,700,000 | +100.0% | 0.92% | – |
| ARRS | New | ARRIS INTL INC | $109,441,000 | – | 3,580,000 | +100.0% | 0.80% | – |
| LBTYK | Sell | LIBERTY GLOBAL PLC | $101,904,000 | -48.2% | 4,937,202 | -29.4% | 0.75% | -35.8% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $93,931,000 | -9.0% | 1,499,297 | +2.9% | 0.69% | +13.0% |
| XLRN | Buy | ACCELERON PHARMA INC | $91,455,000 | -13.2% | 2,100,000 | +14.1% | 0.67% | +7.9% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $81,938,000 | +5.2% | 5,750,000 | +12.2% | 0.60% | +30.7% |
| MYOK | Buy | MYOKARDIA INC | $78,190,000 | -21.7% | 1,600,278 | +4.5% | 0.57% | -2.9% |
| ZGNX | Buy | ZOGENIX INC | $74,761,000 | -16.1% | 2,050,500 | +14.2% | 0.55% | +4.2% |
| P | New | PANDORA MEDIA INC | $74,468,000 | – | 9,205,000 | +100.0% | 0.55% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $69,843,000 | +121.8% | 640,000 | +228.2% | 0.51% | +175.3% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $65,518,000 | -11.6% | 925,000 | +6.6% | 0.48% | +9.6% |
| CVS | New | CVS HEALTH CORP | $60,934,000 | – | 930,000 | +100.0% | 0.45% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $59,523,000 | +14.3% | 1,450,000 | +5.8% | 0.44% | +41.6% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $55,146,000 | +33.8% | 1,300,000 | +48.6% | 0.40% | +66.3% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $50,666,000 | -4.7% | 5,725,000 | +21.2% | 0.37% | +18.2% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $47,635,000 | -11.6% | 3,500,000 | +5.7% | 0.35% | +9.7% |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $43,717,000 | +14.3% | 2,381,119 | +33.0% | 0.32% | +42.0% |
| NVCR | Sell | NOVOCURE LTD | $41,850,000 | -40.8% | 1,250,000 | -7.4% | 0.31% | -26.6% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $40,101,000 | +65.7% | 550,000 | +98.9% | 0.29% | +105.6% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $39,270,000 | -28.7% | 700,000 | +3.9% | 0.29% | -11.4% |
| EXEL | Buy | EXELIXIS INC | $39,340,000 | +105.6% | 2,000,000 | +85.2% | 0.29% | +154.9% |
| NXPI | Sell | NXP SEMICONDUCTORS N V | $39,205,000 | -72.2% | 535,000 | -67.6% | 0.29% | -65.5% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $38,316,000 | -56.6% | 400,000 | -36.0% | 0.28% | -46.1% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $35,713,000 | -20.9% | 1,250,000 | +22.7% | 0.26% | -1.9% |
| FGEN | Sell | FIBROGEN INC | $34,710,000 | -59.0% | 750,000 | -46.2% | 0.25% | -49.3% |
| RDUS | RADIUS HEALTH INC | $33,692,000 | -7.4% | 2,043,149 | 0.0% | 0.25% | +14.9% | |
| BPY | Buy | BROOKFIELD PPTY PARTNERS L Punit ltd partn | $33,449,000 | +101.6% | 2,075,000 | +161.2% | 0.24% | +150.0% |
| RC | New | READY CAP CORP | $30,471,000 | – | 2,203,239 | +100.0% | 0.22% | – |
| ORBK | Buy | ORBOTECH LTDord | $30,290,000 | +121.6% | 535,721 | +132.9% | 0.22% | +174.1% |
| FATE | Buy | FATE THERAPEUTICS INC | $28,226,000 | +226.9% | 2,200,000 | +315.1% | 0.21% | +305.9% |
| PTCT | Buy | PTC THERAPEUTICS INC | $24,024,000 | +21.7% | 700,000 | +66.7% | 0.18% | +50.4% |
| Buy | PTC THERAPEUTICS INCnote 3.000% 8/1 | $23,602,000 | +11.8% | 24,130,000 | +31.5% | 0.17% | +38.4% | |
| ZYME | Buy | ZYMEWORKS INC | $23,121,000 | +10.3% | 1,575,000 | +18.0% | 0.17% | +37.1% |
| CDXS | Buy | CODEXIS INC | $19,289,000 | +12.5% | 1,155,000 | +15.5% | 0.14% | +39.6% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $18,630,000 | – | 1,500,000 | +100.0% | 0.14% | – |
| SVRA | Buy | SAVARA INC | $18,357,000 | -32.0% | 2,425,000 | +0.3% | 0.14% | -15.1% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $18,300,000 | +37.9% | 2,000,000 | +86.9% | 0.13% | +71.8% |
| BUD | Sell | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $18,153,000 | -29.3% | 275,843 | -5.9% | 0.13% | -12.5% |
| CLVS | New | CLOVIS ONCOLOGY INC | $17,960,000 | – | 1,000,000 | +100.0% | 0.13% | – |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $17,643,000 | -22.1% | 4,200,820 | +16.3% | 0.13% | -3.7% |
| CCXI | Buy | CHEMOCENTRYX INC | $15,820,000 | +8.8% | 1,450,000 | +26.1% | 0.12% | +34.9% |
| SHPG | SHIRE PLCsponsored adr | $15,204,000 | -3.6% | 87,000 | 0.0% | 0.11% | +19.4% | |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $14,804,000 | -35.9% | 2,199,674 | -1.9% | 0.11% | -19.9% |
| QTNT | New | QUOTIENT LTD | $14,688,000 | – | 2,400,000 | +100.0% | 0.11% | – |
| BMS | Buy | BEMIS INC | $14,512,000 | +44.5% | 316,160 | +53.0% | 0.11% | +79.7% |
| ILPT | New | INDUSTRIAL LOGISTICS PPTYS T | $12,009,000 | – | 610,545 | +100.0% | 0.09% | – |
| APTX | APTINYX INC | $11,082,000 | -42.9% | 670,000 | 0.0% | 0.08% | -29.6% | |
| AVRO | Buy | AVROBIO INC | $10,823,000 | -55.1% | 650,000 | +39.8% | 0.08% | -44.4% |
| New | CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $10,475,000 | – | 14,750,000 | +100.0% | 0.08% | – | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $10,449,000 | -29.7% | 900,000 | 0.0% | 0.08% | -12.5% | |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $9,587,000 | +162.4% | 350,000 | +180.0% | 0.07% | +218.2% |
| ZFGN | Buy | ZAFGEN INC | $8,786,000 | -53.7% | 1,775,000 | +9.2% | 0.06% | -42.9% |
| MLNX | New | MELLANOX TECHNOLOGIES LTD | $8,776,000 | – | 95,000 | +100.0% | 0.06% | – |
| VYGR | VOYAGER THERAPEUTICS INC | $8,546,000 | -50.3% | 909,158 | 0.0% | 0.06% | -38.2% | |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $7,917,000 | -28.9% | 350,000 | +16.7% | 0.06% | -12.1% |
| VOYA | VOYA FINL INC | $7,426,000 | -19.2% | 185,000 | 0.0% | 0.05% | 0.0% | |
| THOR | New | SYNTHORX INC | $6,710,000 | – | 386,092 | +100.0% | 0.05% | – |
| TBIO | Buy | TRANSLATE BIO INC | $3,750,000 | -16.7% | 500,000 | +11.1% | 0.03% | 0.0% |
| GCVRZ | SANOFIright 12/31/2020 | $3,277,000 | -14.3% | 6,827,805 | 0.0% | 0.02% | +4.3% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $2,848,000 | -47.5% | 250,000 | 0.0% | 0.02% | -34.4% | |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $2,860,000 | -29.6% | 95,365 | -32.8% | 0.02% | -12.5% |
| BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $2,920,000 | -77.8% | 1,000,000 | -53.2% | 0.02% | -73.1% |
| AVA | Sell | AVISTA CORP | $2,672,000 | -96.4% | 62,900 | -95.7% | 0.02% | -95.4% |
| PFNX | PFENEX INC | $1,914,000 | -37.6% | 600,000 | 0.0% | 0.01% | -22.2% | |
| TYME | Sell | TYME TECHNOLOGIES INC | $1,110,000 | -1.6% | 300,857 | -25.9% | 0.01% | +14.3% |
| RMED | Sell | RA MED SYS INC | $305,000 | -88.8% | 38,313 | -74.5% | 0.00% | -87.5% |
| Exit | N/An/a | $0 | – | 0 | +100.0% | 0.00% | – | |
| AKRXQ | Exit | AKORN INC | $0 | – | -70,000 | -100.0% | -0.01% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -150,000 | -100.0% | -0.01% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -500,000 | -100.0% | -0.02% | – |
| YMAB | Exit | Y MABS THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.02% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.03% | – |
| Exit | SOLARCITY CORPnote 2.750%11/0 | $0 | – | -5,000,000 | -100.0% | -0.03% | – | |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -400,000 | -100.0% | -0.04% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -700,000 | -100.0% | -0.07% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -295,000 | -100.0% | -0.08% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -550,000 | -100.0% | -0.09% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -410,000 | -100.0% | -0.11% | – |
| IDTI | Exit | INTEGRATED DEVICE TECHNOLOGY | $0 | – | -640,000 | -100.0% | -0.18% | – |
| SLD | Exit | SUTHERLAND ASSET MGMT CORP M | $0 | – | -2,203,239 | -100.0% | -0.22% | – |
| CA | Exit | CA INC | $0 | – | -1,382,361 | -100.0% | -0.36% | – |
| SINA | Exit | SINA CORPord | $0 | – | -1,124,224 | -100.0% | -0.46% | – |
| BPR | Exit | BROOKFIELD PROPERTY REIT INCcl a | $0 | – | -8,054,215 | -100.0% | -1.00% | – |
| EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -5,615,000 | -100.0% | -1.52% | – |
| COL | Exit | ROCKWELL COLLINS INC | $0 | – | -4,155,000 | -100.0% | -3.45% | – |
| DVMT | Exit | DELL TECHNOLOGIES INC | $0 | – | -6,389,000 | -100.0% | -3.66% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -11,895,000 | -100.0% | -6.68% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -7,425,000 | -100.0% | -8.90% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.